Sanofi-Aventis U.S. LLC v. Eli Lilly and Company
1:14-cv-00113
Overview
Parties
Movant
Thomas E. Wettermann NPE (Individual / Inventor)
Represented By
1 Attorneys ListedGreenberg Traurig, LLP
The Nemours Building, 1007 North Orange Street, Suite 1200
David M. Frischkorn NPE (Individual / Inventor)
Represented By
1 Attorneys ListedGreenberg Traurig, LLP
The Nemours Building, 1007 North Orange Street, Suite 1200
Defendant
Sanofi-Aventis U.S. LLC Operating Company
Represented By
10 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Delaware Department of Justice
Delaware Department of Justice, 820 North French Street
Eli Lilly and Company Operating Company
Represented By
9 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Plaintiff
Sanofi-Aventis Deutschland GmbH NPE (Individual / Inventor)
Represented By
4 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Ashby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Delaware Department of Justice
Delaware Department of Justice, 820 North French Street
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Mylan Pharmaceuticals Inc., et al. v. Sanofi Aventis Deutschland GmbH et al.
Mylan Pharmaceuticals Inc., et al. v. Sanofi Aventis Deutschland GmbH et al.
Sanofi-Aventis U.S. LLC v. Merck Sharp & Dohme Corp.
Sanofi-Aventis U.S. LLC v. Eli Lilly and Company
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8556864
Drive mechanisms suitable for use in drug delivery devices
|
Filed: 2011-03-30
Issued: 2013-10-15
|
Expired (Term Ended)
Expires: 2024-12-29
|
|
|
US8603044
Pen-type injector
|
Filed: 2013-06-04
Issued: 2013-12-10
|
Active (6.5 yrs remaining)
Expires: 2033-06-04
|
|
|
US7476652
Acidic insulin preparations having improved stability
|
Filed: 2005-03-25
Issued: 2009-01-13
|
Expired (Term Ended)
Expires: 2023-07-23
|
|
|
US7713930
Acidic insulin preparations having improved stability
|
Filed: 2008-12-04
Issued: 2010-05-11
|
Active (2.0 yrs remaining)
Expires: 2028-12-04
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
18
Dispositive
5
Granted
0
Denied
1
Pending / Review
15
Motions by Category
Key Dispositive Motions & Rulings